skip to main content

    Updated Visitor Guidelines

 

MENU

 

A New Type of RNA Protein Called THOR Plays a Role in Cancer Development

Researchers at the University of Michigan Rogel Cancer Center uncovered a novel gene they named THOR while investigating previously unexplored regions of the human genome -- or the human genome’s dark matter.

Women in Medicine Say #MeToo

After defining the scope of sexual harassment in medicine, a physician says sharing stories and a national reckoning offer hope for progress.

Breast Cancer Recurrence Risk Continues Years After Treatment

Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators published in the New England Journal of Medicine.

New Device Tracks Which Cancer Cells Cause Metastasis

As cancer grows, it evolves. Individual cells become more aggressive, break away to flow through the body and spread to distant areas. What if there were a way to find those early aggressors? How are they different from the rest of the cells? And more importantly: Is there a way to stop them before they spread?

Precision Medicine Test for Breast Cancer Helps Guide Chemotherapy Decisions

A new study finds doctors are appropriately using a genetic test to measure breast cancer recurrence risk and to make tailored treatment recommendations.

The Future of Breast Cancer Research

University of Michigan Rogel Cancer Center breast cancer researchers discuss the amazing progress of breast cancer research over the past decades and look ahead to the day when it's understood exactly how and why breast cancer spreads so it can be stopped.

Treg Cell Activity May Limit Immunotherapy

Regulatory T cells, or Treg cells, work within the immune system to suppress immune function. Cancer immunotherapy treatments work by supercharging the immune system to fight cancer. So when Tregs come in and suppress the immune response, it shuts down the cancer-fighting effect. But eliminating the Tregs doesn’t help. Researchers have tried, but a clinical trial testing that idea showed no benefit to patients.

Pages